Membrane Lipid Dynamics in Human Promyelocytic Leukemia Cells Sensitive and Resistant to 12-O-Tetradecanoylphorbol-13-acetate Induction of Differentiation

Cancer Research

Volumn 44, Issue , 1984, Pages 5550-5554

  Fisher, Paul B ^a   Schachter, David ^a   Abbott, Richard E ^a   Callaham, Michael F ^a   Huberman, Eliezer ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PHORBOL 13 ACETATE 12 MYRISTATE;

CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETICULOENDOTHELIAL SYSTEM;

CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL MEMBRANE; DRUG RESISTANCE; FLUORESCENCE POLARIZATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; MURAMIDASE; PHORBOLS; TETRADECANOYLPHORBOL ACETATE; VARIATION (GENETICS);

EID: 0021743383     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ashendel, C. L., Staller, J. M., and Boutwell, R. K. Identification of a calcium-and phospholipid-dependent phorbool ester binding activity in the soluble fraction of mouse tissues. Biochem. Biophys. Res. Commun., 111: 340-345, 1983
2. Ben-Bassat, H., Poliak, S., Rosenbaum, S. M., Naparstek, E., Shouval, D., and Inbar, M. Fluidity of membrane liqids and lateral mobility of concanavalin A receptors in cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias. Cancer Res., 37: 1307-1312, 1977.
3. Boutwell, R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit. Rev. Toxicol., 2: 419-443, 1974.
4. Braun, A. G., Buckner, C. A., and Nichinson, B. B. Plasma membrane alterations due to promoters and antipromoters. Teratog. Carcinog. Mutagen., 1: 417-427, 1981.
5. Butier-Grala, E., and Herschman, H. R. Variants of 3T3 cels lacking mitogenic response to the tumor promoter tetradecanoyl-phorbol-acetate. J. Cell. Physiol., 107: 59-68, 1981.
6. Castagna, M., Rochette-Egly, C., Rosenfeld, C., and Mishal, Z. Altered lipid microviscosity in lymphobiastotd cells treated with 12-O-tetradecanoyiphorbol-13-acetate, a tumor promoter. FEBS Lett., 100: 62-66, 1979.
7. Cogan, U., and Schachter, O. Asymmetry of ipid dynamics In human erythrocyte membranes studied with impermeant fluorophores. Biochemistry, 20: 6396-6403, 1981.
8. Colburn, N. H., Srinivas, L., and Wendel, E. J. Response of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter resistant variants for mechanism studies. J. Cell. Biochem., 18: 261-270, 1982.
9. Cooper, R. A., Braunwald, A. D., and Kuo, A. L. Phorbol ester induction of leukemic cel differentiation is a membrane-mediated process. Proc. Natl. Acad. Sci. USA. 79, 2865-2869, 1982.
10. Deletes, K. B., Nagle, D. S., and Blumberg, P. M. Specific binding of phorbol ester tumor promoters to mouse skin. Cel, 19: 1025-1032, 1980.
11. Deleers, M., and Malaisse, W. J. Binding of tumor-promoting and biologically Inactive phorbol esters to artificial membranes. Cancer Lett., 17: 135-140, 1982.
12. Deleers, M., Ruyscchaert, J. M., and Malaisse, W. J. Interaction between phorbol esters and phosphollipid in a monolayer model membrane. Chem.-Biol. Interact., 42; 271-278, 1982.
13. Diamond, L., O'Brien, T. G., and Rovera, G. Tumor promoters: effects on proliferation and differentiation of cells in culture. Life Sci., 23: 1979-1988, 1978.
14. Driedger, P. E., and Blumberg, P. M. Specific binding of phorbol ester tumor promoters. Proc. Natl. Acad. Sci. USA, 77, 567-571, 1981.
15. Fibach, E., Yamasaki, H., Weinstein, I. B., Marks, P. A., and Rifilnd, R. A. Heterogeneity of murine erythroleukemia cells with respect to tumor promotermediated inhibition of cell differentiation. Cancer Res., 38: 3685-3688, 1978.
16. Fisher, P. B. Enhancement of viral transformation and expression of the transformed phenotype by tumor promoters. In: T. J. Slaga (ed.). Tumor Promotion and Cocarcinogenesis In Vitro, Mechanisms of Tumor Promotion, pp. 57-123. West Palm Beach, FL: CRC Press Inc., 1984.
17. Fisher, P. B., Bozzone, J. H., and Weinstein, I. B. Tumor promoters and epidermal growth factor stimulate anchorage-independent growth of adenovirus transformed rat embryo cells. Cell, 18: 695-705, 1979.
18. Fisher, P. B., Cogan, U., Horowitz, A. D., Schachter, D., and Weinstein, I. B. TPA-resistance in Friend erythroleukemia cells: role of membrane lipid fluidity. Biochem. Biophys. Res. Commun., 100: 370-376, 1981.
19. Fisher, P. B., Flamm, M., Schachter, D., and Weinstein, I. B. Tumor promoters induce membrane changes detected by fluorescence polarization. Biochem. Biophys. Res. Commun., 86: 1063-1068, 1979.
20. Fisher, P. B., Weinstein, I. B., Eisenberg, D., and Ginsberg, H. S. Interactions between adenovirus, a tumor promoter, and chemical carcinogens in the transformation of rat embryo cell cultures. Proc. Natl. Acad. Sci. USA, 75: 2311-2314, 1978.
21. Guy, G. R., and Murray, A. W. Modulation of HeLa cell phospholipid metabolism and ornithine decarboxylase activity by tumor promoters: regulation of response to phorbol-12, 13-dibutyrate by receptor occupancy time. Biochem. Biophys. Res. Commun., 106: 1398-1404, 1982.
22. Hecker, E. Isolation and characterization of the carcinogenic principles from croton oil. Methods Cancer Res., 6: 439-484, 1971.
23. Hoffman, D. R., and Huberman, E. The control pf phospholipid methyiatkm by phorbol diesters in differentiating human myeloid HL-60 leukemia cels. Carcinogenesis (Lond.), 3: 875-880, 1982.
24. Horowitz, A. D., Greenebaum, E., and Weinstein, I. B. Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and an inhibitor of receptor binding in biologic fluids. Proc. Natl. Acad. Sci. USA, 78; 2315-2319, 1981.
25. Huberman, E., Braslawski, G. R., Calaham, M. F., and Fujiki, H. Induction of differentiation of human promyetocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetate. Carcinogenesis (Lond.), 3: 111-114, 1982.
26. Huberman, E., Weeks, C., Herrmann, A., Calaham, M., and Siaga, T. Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyetocytic leukemia cells. Proc. Natl. Acad. Sci. USA, 78; 1062-1066, 1981.
27. Kamovsky, M. J., Kleinfeld, A. M., Hoover, R. L., and Klausner, R. D. The concept of ipid domains in membranes. J. Cell. Bid., 94: 1-6, 1982.
28. Kennedy, A., Mondal, S., Hetdelberger, C., and Little, J. B. Enhancement of X-ray transformation by 12-O-tetradecanoyiphorbol 3-acetate in a cloned line of C3H mouse embryo cels. Cancer Res., 38: 439-443, 1978.
29. Mondal, S., Brankow, D. W., and Heidelberger, C. Two-stage chemical oncogenesis In culture of C3H/10T-V2 cells. Cancer Res., 36: 2254-2260, 1976.
30. Pendergast, F. G., Haugland, R. P., Callahan, P. J., and Bodeau, D. 1-(4-(trimethytamino) phenyl)-6-phenylhexa-1, 3, 5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of Ipid bilayers. Biochemistry, 20: 7333-7338, 1981.
31. Posts, G., Papahadjopoulos, D., and Nicolson, G. L. Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. Proc. Natl. Acad. Sci. USA, 72: 4430-4434, 1975.
32. Pryme, I. F., Lillehaug, J. R., Fjose, A., and Kleppe, K. The nuclear-associated endoplasmic reticulum is an early target for the action of the tumor promoter 12-O-tetradecanoytphorbol 13-acetate in C3H 10T Vi fibroblasts. FEBS Lett., 152: 17-20, 1983.
33. Schachter, D., and Shinitzky, M. Fluorescence polarization studies of rat intestinal microvilus membranes. J. Clin. Invest., 59: 536-548, 1977.
34. Shoyab, M., and Todaro, G. T. Specific high affinity cell membrane receptors for biologically active phorbol and ingenol esters. Nature (Lond.), 288; 451-455, 1980.
35. Siaga, T. J., Sivak, A., and Boutwel, R. K. (eds.). In: Mechanisms of Tumor Promotion and Cocarcinogenesis, Vol. 2. New York: Raven Press, 1978.
36. Solanki, V., Siaga, T. J., Calaham, M., and Huberman, E. Down regulation of specific binding of [20-3H]phorbol 12, 13-dibutyrate and phorbol ester-induced differentiation of human promyetocytic leukemia cells. Proc. Natl. Acad. Sci. USA, 78: 1722-1725, 1981.
37. Tran, P. L., Castagna, M., Sala, M., Vassent, G., Horowitz, A. D., Schachter, D., and Weinstein, I. B. Differential effect of tumor promoters on phorbol ester-receptor binding and membrane fluorescence anisotropy in C3H 10 % cells. Eur. J. Biochem., 130: 155-160, 1983.
38. Weinstein, I. B., Lee, L. S. Fisher, P. B., Mufson, R. A., and Yamasaki, H. Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation and effects on cell membranes. J. Supramol. Struct., 12: 195-208, 1979.
39. Yamasaki, H., Drevon, C., and Martel, N. Specific binding of phorbol esters to Friend erythroleukemia cells--general properties, down regulation and relationship to cel differentiation. Carcinogenesis (Lond.), 3; 905-910, 1982.
40. Yamasiaki, H., Mufson, R. A., and Weinstein, I. B. Phorbol ester induced prostaglandin synthesis and [3H TPA metabolism by TPA-sensitive and TPA-resistant Friend erythroleukemia cells. Biochem. Biophys. Res. Commun., 89: 1018-1025, 1979.